Cortexyme Inc.   Report issue

For profit Phase 1 Phase 3
Founded: San Francisco CA United States (2012)

Organization Overview

First Clinical Trial
2017
NCT03331900
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cortexyme Inc.